Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Fukai and Associates
1167
mi
from 43215
Louisville, CO
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Fukai and Associates
1167
mi
from 43215
Louisville, CO
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Peter C. Donshik, MD, PC
552
mi
from 43215
Bloomfield, CT
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Peter C. Donshik, MD, PC
552
mi
from 43215
Bloomfield, CT
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Dr. Ted Brink and Associates
678
mi
from 43215
Jacksonville, FL
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Dr. Ted Brink and Associates
678
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Jack J. Yager, OD
794
mi
from 43215
Orlando, FL
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Jack J. Yager, OD
794
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Clayton Eye Center
446
mi
from 43215
Morrow, GA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Clayton Eye Center
446
mi
from 43215
Morrow, GA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Eyecare Associates
316
mi
from 43215
Bloomington, IL
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Eyecare Associates
316
mi
from 43215
Bloomington, IL
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Drs. Hawks, Besler & Rogers
640
mi
from 43215
Gardner, KA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Drs. Hawks, Besler & Rogers
640
mi
from 43215
Gardner, KA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Lee Rigel
205
mi
from 43215
East Lansing, MI
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Lee Rigel
205
mi
from 43215
East Lansing, MI
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Univ Missouri at St. Louis, College of Optometry
398
mi
from 43215
St. Louis, MO
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Univ Missouri at St. Louis, College of Optometry
398
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
InSight Eyecare
577
mi
from 43215
Warrensburg, MO
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
InSight Eyecare
577
mi
from 43215
Warrensburg, MO
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Drs. Quinn, Quinn and Associates
65
mi
from 43215
Athens, OH
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Drs. Quinn, Quinn and Associates
65
mi
from 43215
Athens, OH
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Central Ohio Eyecare
3
mi
from 43215
Columbus, OH
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Central Ohio Eyecare
3
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Kenji Hamada, OD
2082
mi
from 43215
Grants Pass, OR
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Kenji Hamada, OD
2082
mi
from 43215
Grants Pass, OR
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
West Hills Vision Center
152
mi
from 43215
Moon Township, PA
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
West Hills Vision Center
152
mi
from 43215
Moon Township, PA
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Kenneth A. Young, OD
283
mi
from 43215
Brentwood, TN
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Kenneth A. Young, OD
283
mi
from 43215
Brentwood, TN
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Gary W. Jerkins, MD
332
mi
from 43215
Nashville, TN
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Gary W. Jerkins, MD
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Premier Vision
1078
mi
from 43215
Amarillo, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Premier Vision
1078
mi
from 43215
Amarillo, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Charles Wegman, OD
908
mi
from 43215
Carrollton, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Charles Wegman, OD
908
mi
from 43215
Carrollton, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Wishnow-Sugar Vision Group
1007
mi
from 43215
Katy, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Wishnow-Sugar Vision Group
1007
mi
from 43215
Katy, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
First Eye Care Plano
896
mi
from 43215
Plano, TX
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
First Eye Care Plano
896
mi
from 43215
Plano, TX
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Dr. William Bogus
1512
mi
from 43215
Salt Lake City, UT
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Dr. William Bogus
1512
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Scott Jens, OD
398
mi
from 43215
Middleton, WI
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Scott Jens, OD
398
mi
from 43215
Middleton, WI
Click here to add this to my saved trials
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated:  2/24/2016
Snowy Range Vision Center
1183
mi
from 43215
Laramie, WY
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
Status: Enrolling
Updated: 2/24/2016
Snowy Range Vision Center
1183
mi
from 43215
Laramie, WY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
UAB School of Optometry
492
mi
from 43215
Birmingham, AL
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
UAB School of Optometry
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Sall Research Medical Center, Inc.
1968
mi
from 43215
Artesia, CA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Sall Research Medical Center, Inc.
1968
mi
from 43215
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
North Valley Eye Medical Group, Inc.
1978
mi
from 43215
Mission Hills, CA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
North Valley Eye Medical Group, Inc.
1978
mi
from 43215
Mission Hills, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Wolstan & Goldberg Eye Associates
1984
mi
from 43215
Torrance, CA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Wolstan & Goldberg Eye Associates
1984
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Tauber Eye Center
619
mi
from 43215
Kansas City, MO
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Tauber Eye Center
619
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
South Shore Eye Center, LLP
503
mi
from 43215
Wantagh, NY
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
South Shore Eye Center, LLP
503
mi
from 43215
Wantagh, NY
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Abrams Eye Center
127
mi
from 43215
Cleveland, OH
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Abrams Eye Center
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated:  2/26/2016
Virginia Eye Consultants
426
mi
from 43215
Norfolk, VA
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease
Status: Enrolling
Updated: 2/26/2016
Virginia Eye Consultants
426
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated:  3/1/2016
The Chicago Lighthouse for People Who Are Blind or Visually Impaired
275
mi
from 43215
Chicago, IL
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated: 3/1/2016
The Chicago Lighthouse for People Who Are Blind or Visually Impaired
275
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated:  3/1/2016
Lighthouse Guild
479
mi
from 43215
New York, NY
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated: 3/1/2016
Lighthouse Guild
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated:  3/1/2016
Wicab, Inc.
398
mi
from 43215
Middleton, WI
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Status: Enrolling
Updated: 3/1/2016
Wicab, Inc.
398
mi
from 43215
Middleton, WI
Click here to add this to my saved trials
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
Status: Enrolling
Updated:  3/1/2016
Hazleton Eye Specialists
374
mi
from 43215
Hazleton, PA
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
Status: Enrolling
Updated: 3/1/2016
Hazleton Eye Specialists
374
mi
from 43215
Hazleton, PA
Click here to add this to my saved trials
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
A 24-month Randomized, Double-masked, Sham Controlled, Multicenter, Phase IIIB Study Comparing Photodynamic Therapy With Verteporfin (Visudyne®) Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide (1 mg and 4 mg) Versus Visudyne® Plus Intravitreal Pegaptanib(Macugen®) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  3/3/2016
Novartis Investigational Site
1065
mi
from 43215
Austin, TX
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
A 24-month Randomized, Double-masked, Sham Controlled, Multicenter, Phase IIIB Study Comparing Photodynamic Therapy With Verteporfin (Visudyne®) Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide (1 mg and 4 mg) Versus Visudyne® Plus Intravitreal Pegaptanib(Macugen®) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 3/3/2016
Novartis Investigational Site
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
604
mi
from 43215
Worcester, MA
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
509
mi
from 43215
Slingerlands, NY
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
509
mi
from 43215
Slingerlands, NY
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Investigator Site 102
mi
from 43215
Brno,
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Investigator Site 102
mi
from 43215
Brno,
Click here to add this to my saved trials
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated:  3/7/2016
Hunter Health Clinic
783
mi
from 43215
Wichita, KA
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated: 3/7/2016
Hunter Health Clinic
783
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated:  3/7/2016
Yellowhawk Tribal Health Center
1838
mi
from 43215
Pendleton, OR
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy
Status: Enrolling
Updated: 3/7/2016
Yellowhawk Tribal Health Center
1838
mi
from 43215
Pendleton, OR
Click here to add this to my saved trials
Determinants of Compliance With Glaucoma Therapy
Determinants of Compliance With Glaucoma Therapy
Status: Enrolling
Updated:  3/7/2016
Devers Eye Institute
2026
mi
from 43215
Portland, OR
Determinants of Compliance With Glaucoma Therapy
Determinants of Compliance With Glaucoma Therapy
Status: Enrolling
Updated: 3/7/2016
Devers Eye Institute
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Dextromethorphan for Diabetic Macular Edema
A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2)
Status: Enrolling
Updated:  3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Dextromethorphan for Diabetic Macular Edema
A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2)
Status: Enrolling
Updated: 3/9/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated:  3/10/2016
University of Colorado Eye Center
1153
mi
from 43215
Aurora, CO
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated: 3/10/2016
University of Colorado Eye Center
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Status: Enrolling
Updated:  3/14/2016
Abbott Vascular
2090
mi
from 43215
Santa Clara, CA
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Status: Enrolling
Updated: 3/14/2016
Abbott Vascular
2090
mi
from 43215
Santa Clara, CA
Click here to add this to my saved trials
Validation of TearLab Osmometer - Human Factor Usability Report
Validation of TearLab Osmometer - Human Factor Usability Report
Status: Enrolling
Updated:  3/14/2016
Gordon Binder Weiss Vision Institute
1947
mi
from 43215
San Diego, CA
Validation of TearLab Osmometer - Human Factor Usability Report
Validation of TearLab Osmometer - Human Factor Usability Report
Status: Enrolling
Updated: 3/14/2016
Gordon Binder Weiss Vision Institute
1947
mi
from 43215
San Diego, CA
Click here to add this to my saved trials